Industry Favors Predictability Over Speed In Next Round Of MDUFMA
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA-commissioned report by The Lewin Group finds that senior device industry staffers are more interested in improving the predictability of the FDA premarket review process than on pushing the agency to accelerate its performance.